NutriBand (NTRB) EPS (Basic) Growth (5y) (2021 - 2026)
NutriBand (NTRB) EPS (Basic) Growth (5y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | NutriBand | 46.38 Mn | 42.37 Mn | 196,801.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -19.08% |
| Jan 31, 2026 | 24.30% |
| Oct 31, 2025 | -118.45% |
| Jul 31, 2025 | -127.14% |
| Apr 30, 2025 | -25.77% |
| Jan 31, 2025 | -28.36% |
| Oct 31, 2024 | -0.61% |
| Jul 31, 2024 | -16.71% |
| Apr 30, 2024 | -25.43% |
| Jan 31, 2024 | -23.42% |
| Oct 31, 2023 | -23.96% |
| Jul 31, 2023 | 18.98% |
| Apr 30, 2023 | -11.99% |
| Jan 31, 2023 | 14.51% |
| Oct 31, 2022 | -50.61% |
| Jul 31, 2022 | -49.93% |
| Apr 30, 2022 | -57.14% |
| Jan 31, 2022 | -103.05% |
| Oct 31, 2021 | -119.30% |
| Jul 31, 2021 | -66.63% |